期刊文献+

IP-10和Mig及其受体与Graves病和桥本甲状腺炎 被引量:2

IP-10,Mig and their receptor-CXCR3 in Graves' disease and Hashimoto's thyroiditis
原文传递
导出
摘要 Graves病和桥本甲状腺炎均属自身免疫性甲状腺疾病,其主要特征为甲状腺内不同程度的淋巴细胞和浆细胞的浸润、活化及针对自身抗原的免疫反应。CXC亚族趋化因子干扰素-γ诱导蛋白-10(IP-10)和干扰素-γ诱导单核细胞因子(Mig)在多种炎症细胞因子的调节下,通过与其受体CX-CR3结合使CXCR3阳性淋巴细胞向甲状腺炎症病灶迁移。活化的淋巴细胞通过介导抗原特异性的免疫应答和释放细胞因子导致腺体破坏继而损害甲状腺功能,在Graves病和桥本甲状腺炎的发生、发展中起重要作用。 Graves' disease and Hashimoto's thyroiditis belong to autoimmune thyroid disease. They are characterized by recruitment and activition of lymphocytes in thyroid and reactivation to self thyroid antigens. IFN-γ inducible protein-10 (IP-10) and monokine induced by IFN-γ (Mig) binding to the CXCR3 receptor are considered important in the migration of CXCR3 positive lymphocytes to the thyroid inflammatory foci under the regulation of several inflammatory cytokines. The activated lymphocytes can induce the destruction of the gland and later develop thyroid failure through reactivition of self thyroid antigens and production of cytokines. Therefore IP-10, Mig and CXCR3 play important roles in the pathogenesis of Graves' disease and Hashimoto's thyroiditis.
作者 刘蓉 江昌新
出处 《国际内分泌代谢杂志》 2006年第5期336-336,337-338,共3页 International Journal of Endocrinology and Metabolism
关键词 GRAVES病 桥本甲状腺炎 趋化因子 干扰素-γ诱导蛋白-10 干扰素-γ诱导单核细胞因子 Graves' disease Hashimoto' s thyroiditis Chemokine IFN-γ inducible protein-10 Monokine induced by IFN-γ
  • 相关文献

参考文献13

  • 1Lasagni L,Francalanci M,Annunziato F,et al.An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10,Mig,and I-TAC,and acts as functional receptor for platelet factor 4.J Exp Med,2003,197:1537-1549.
  • 2Booth V,Clark-Lewis I,Sykes BD,et al.NMR structure of CXCR3 binding chemokine CXCL11 (ITAC).Protein Sci,2004,13:2022-2028.
  • 3Colvin RA,Campanella GS,Sun J,et al.Intracellular domains of CXCR3 that mediate CXCL9,CXCL10,and CXCL11 function.J Biol Chem,2004,279:30219-30227.
  • 4Garcia-Lopez MA,Sanchez-Madrid F,Rodriguez-Frade JM,et al.CXCR3 chemokine receptor distribution in normal and inflamed tissues:expression on activated lymphocytes,endothelial cells,and dendritic cells.Lab Invest,2001,81:409-418.
  • 5Garcia-Lopez MA,Sancho D,Sanchez-Madrid F,et al.Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3 + lymphocytes.J Clin Endocrinol Metab,2001,86:5008-5016.
  • 6Romagnani P,Rotondi M,Lazzeri E,et al.Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.Am J Pathol,2002,161:195-206.
  • 7Antonelli A,Rotondi M,Fallahi P,et al.Increase of interferon-gammainducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease,and modulation by methimazole therapy.Clin Endocrinol(Oxf),2006,64:189-195.
  • 8Antonelli A,Rotondi M,Fallahi P,et al.High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism.J Clin Endocrinol Metab,2004,89:5496-5499.
  • 9Antonelli A,Rotondi M,Fallahi P,et al.Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis.Eur J Endocrinol,2005,152:171-177.
  • 10Weetman AP.Autoimmune thyroid disease:propagation and progression.Eur J Endocrinol,2003,148:1-9.

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部